DOBUTamine - 0409-2025-20 - (DOBUTAMINE HYDROCHLORIDE)

Alphabetical Index


Drug Information of DOBUTamine

Product NDC: 0409-2025
Proprietary Name: DOBUTamine
Non Proprietary Name: DOBUTAMINE HYDROCHLORIDE
Active Ingredient(s): 12.5    mg/mL & nbsp;   DOBUTAMINE HYDROCHLORIDE
Administration Route(s): INTRAVENOUS
Dosage Form(s): INJECTION, SOLUTION
Coding System: National Drug Codes(NDC)

Labeler Information of DOBUTamine

Product NDC: 0409-2025
Labeler Name: Hospira, Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: ANDA074292
Marketing Category: ANDA
Start Marketing Date: 19950216

Package Information of DOBUTamine

Package NDC: 0409-2025-20
Package Description: 10 BOX in 1 CASE (0409-2025-20) > 10 VIAL, SINGLE-DOSE in 1 BOX > 20 mL in 1 VIAL, SINGLE-DOSE

NDC Information of DOBUTamine

NDC Code 0409-2025-20
Proprietary Name DOBUTamine
Package Description 10 BOX in 1 CASE (0409-2025-20) > 10 VIAL, SINGLE-DOSE in 1 BOX > 20 mL in 1 VIAL, SINGLE-DOSE
Product NDC 0409-2025
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name DOBUTAMINE HYDROCHLORIDE
Dosage Form Name INJECTION, SOLUTION
Route Name INTRAVENOUS
Start Marketing Date 19950216
Marketing Category Name ANDA
Labeler Name Hospira, Inc.
Substance Name DOBUTAMINE HYDROCHLORIDE
Strength Number 12.5
Strength Unit mg/mL
Pharmaceutical Classes Adrenergic beta-Agonists [MoA],beta-Adrenergic Agonist [EPC]

Complete Information of DOBUTamine


General Information